EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Capsazepine (CPZ) Inhibits TRPC6 Conductance and Is Protective in Adriamycin-Induced Nephropathy and Diabetic Glomerulopathy

Henning Hagmann, Naghmeh Hassanzadeh Khayyat, Mahsa Matin iD, Cem Oezel, He Chen, Astrid Schauss, Christoph Schell, Thomas Benzing, Stuart Dryer, Paul T Brinkkoetter iD

Cells · 2023

DOI: 10.3390/cells12020271 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Henning Hagmann und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department II of Internal Medicine, University Hospital Cologne, Faculty of Medicine, University of Cologne, 50937 Cologne, Germany. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Transient Receptor Potential Channels, Diabetes Mellitus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Marga Boll Foundation, Else Kröner-Fresenius Foundation, DFG fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reactive oxygen species (ROS), which excessively arise in diabetes and systemic inflammatory diseases, modify cellular lipids and cellular lipid composition leading to altered biophysical properties of cellular membranes. The impact of lipid peroxidation on transmembrane signaling routes is not yet well studied. The canonical transient receptor potential channel 6 (TRPC6) is implicated in the pathogenesis of several forms of glomerular diseases. TRPC6 is sensitive to membrane stretch and relies on a distinct lipid environment. This study investigates the effect of oxidative alterations to plasma membrane lipids on TRPC6 activity and the function of the glomerular filter. Knockout of the anti-oxidative, lipid modifying enzyme paraoxonase 2 (PON2) leads to altered biophysical properties of glomerular epithelial cells, which are called podocytes. Cortical stiffness, quantified by atomic force microscopy, was largely increased in PON2-deficient cultured podocytes. PON2 deficiency markedly enhanced TRPC6 channel currents and channel recovery. Treatment with the amphiphilic substance capsazepine in micromolar doses reduced cortical stiffness and abrogated TRPC6 conductance. In in vivo studies, capsazepine reduced the glomerular phenotype in the model of adriamycin-induced nephropathy in PON2 knockout mice and wildtype littermates. In diabetic AKITA mice, the progression of albuminuria and diabetic kidney disease was delayed. In summary, we provide evidence that the modification of membrane characteristics affects TRPC6 signaling. These results could spur future research to investigate modification of the direct lipid environment of TRPC6 as a future therapeutic strategy in glomerular disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesTransient Receptor Potential ChannelsDiabetes MellitusMiceAnimalsTRPC6 Cation ChannelTRPC Cation ChannelsDoxorubicinMice, KnockoutCapsaicin

Stichwörter der Autor:innen

glomerular diseaselipid peroxidationoxidative stresspodocyteproteinuria

Substanzen

TRPC6 Cation ChannelTransient Receptor Potential ChannelsTRPC Cation ChannelsDoxorubicincapsazepineCapsaicinTrpc6 protein, mouse

Autor:innen und Institutionen

  • Department II of Internal Medicine, University Hospital Cologne, Faculty of Medicine, University of Cologne, 50937 Cologne, Germany.
  • Center for Molecular Medicine Cologne, University Hospital Cologne, Faculty of Medicine, University of Cologne, 50931 Cologne, Germany.
  • Department of Biology and Biochemistry, University of Houston, Houston, TX 77204, USA.
  • Cologne Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases (CECAD), 50931 Cologne, Germany.
  • Institute of Surgical Pathology, Faculty of Medicine, University Medical Center Freiburg, 79106 Freiburg, Germany.
  • Systems Biology of Ageing Cologne (Sybacol), 50931 Cologne, Germany.

ORCID-Profile: Mahsa Matin, Paul T Brinkkoetter

Förderung

  • Marga Boll Foundation
  • Else Kröner-Fresenius Foundation
  • DFG fellowship
  • clinical research unit
  • Germany Ministry for Science and Education

Zitieren

APA

Hagmann, H., Khayyat, N. H., Matin, M., Oezel, C., Chen, H., Schauss, A., Schell, C., Benzing, T., Dryer, S., & Brinkkoetter, P. T. (2023). Capsazepine (CPZ) Inhibits TRPC6 Conductance and Is Protective in Adriamycin-Induced Nephropathy and Diabetic Glomerulopathy. Cells. https://doi.org/10.3390/cells12020271

Vancouver

Hagmann H, Khayyat NH, Matin M, Oezel C, Chen H, Schauss A, et al. Capsazepine (CPZ) Inhibits TRPC6 Conductance and Is Protective in Adriamycin-Induced Nephropathy and Diabetic Glomerulopathy. Cells. 2023. doi:10.3390/cells12020271

BibTeX
@article{Hagmann2023,
  author = {Hagmann, Henning and Khayyat, Naghmeh Hassanzadeh and Matin, Mahsa and Oezel, Cem and Chen, He and Schauss, Astrid and Schell, Christoph and Benzing, Thomas and Dryer, Stuart and Brinkkoetter, Paul T},
  title = {Capsazepine (CPZ) Inhibits TRPC6 Conductance and Is Protective in Adriamycin-Induced Nephropathy and Diabetic Glomerulopathy},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12020271}
}
Kostenlos starten →